Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 752 All time
- Disclosed funding
- $25.4B 616 disclosed amounts
- Median round
- $15.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EI Develops AI-driven wireless technologies for brain health. | $26M | Series B | Healthtech | United States | Investors | |
| VD Vivid DxCompany profile Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions | $15M | Seed | Healthtech | United Kingdom | Investors | |
| M MiraeCompany profile AI-driven continuous care platform for autoimmune disease and other complex chronic conditions AI-driven continuous care platform for autoimmune disease and other complex chronic conditions | $5.4M | Seed | Healthtech | United Kingdom | Investors | |
| NM Navi Medical TechnologiesCompany profile Develops ECG-guided catheter placement technology for neonatal and paediatric care Develops ECG-guided catheter placement technology for neonatal and paediatric care | A$6.8M | Undisclosed | Healthtech | Australia | Investors | |
| DT Dopl TechnologiesCompany profile Developing a robotic ultrasound platform for remote diagnostic exams. Developing a robotic ultrasound platform for remote diagnostic exams. | $6.3M | Seed | Healthtech | United States | Investors | |
| T UK healthtech startup using AI to cut lung disease test time | $19M | Undisclosed | Healthtech | United Kingdom | Investors | |
| PM AI-powered concierge primary care platform | $16M | Undisclosed | Healthtech | United States | Investors | |
| CH Automates the financial infrastructure of American healthcare | $120M | Series DSeries C+ | Healthtech | United States | Investors | |
| P PawPay turns any policy into pet insurance that pays vet directly | Undisclosed | Undisclosed | Healthtech, Fintech | United States | Investors | |
| CT Crystalys TherapeuticsCompany profile Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout | $130M | Series B | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.